1. 119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis. (4th December 2021) Authors: Gu, Yiyou; Alqarihi, Abdullah; Singh, Shakti; Gebremariam, Teclegiorgis; Alkhazraji, Sondus; Youssef, Eman; Andes, David; Ibrahim, Ashraf S Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis. (4th December 2021) Authors: Gu, Yiyou; Alqarihi, Abdullah; Singh, Shakti; Gebremariam, Teclegiorgis; Alkhazraji, Sondus; Youssef, Eman; Andes, David; Ibrahim, Ashraf S Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). (31st December 2020) Authors: Alexander, Barbara D; Cornely, Oliver; Pappas, Peter; Miller, Rachel; Vazquez, Jose A; Ostrosky-Zeichner, Luis; Spec, Andrej; Rautemaa-Richardson, Riina; Krause, Robert; Thompson III, George R; Morse, Caryn; Sanders, John W; Andes, David; Andes, David; Lyon, George; Marty, Francisco M; Silverman,... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 992. Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Vazquez, Jose A; Cornely, Oliver; Koehler, Philipp; Rautemaa-Richardson, Riina; Bazaz, Rohit; Marshall Lyon, G; Marty, Francisco M; Gonzalez-Bocco, Isabel H; Miller, Rachel; Walsh, Thomas J; Pappas, Peter; McCarty, Todd P; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Pr... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Dual‐Responsive Antibiotic‐Loaded Nanoparticle Specifically Binds Pathogens and Overcomes Antimicrobial‐Resistant Infections. Issue 9 (22nd January 2021) Authors: Ye, Mingzhou; Zhao, Yi; Wang, Yuyuan; Zhao, Miao; Yodsanit, Nisakorn; Xie, Ruosen; Andes, David; Gong, Shaoqin Journal: Advanced materials Issue: Volume 33:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Candidemia in the Growing Opioid Epidemic: A Distinct and Emerging Entity. (2nd November 2019) Authors: Andes, David Journal: Clinical infectious diseases Issue: Volume 71:Number 7(2020) Page Start: 1738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action. (April 2013) Authors: Tebbets, Brad; Yu, Zhiguo; Stewart, Douglas; Zhao, Li-Xing; Jiang, Yi; Xu, Li-Hua; Andes, David; Shen, Ben; Klein, Bruce Journal: Medical mycology Issue: Volume 51:Number 3(2013) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. (July 2015) Authors: Verweij, Paul E.; Ananda-Rajah, Michelle; Andes, David; Arendrup, Maiken C.; Brüggemann, Roger J.; Chowdhary, Anuradha; Cornely, Oliver A.; Denning, David W.; Groll, Andreas H.; Izumikawa, Koichi; Kullberg, Bart Jan; Lagrou, Katrien; Maertens, Johan; Meis, Jacques F.; Newton, Pippa; Page, Iain; S... Journal: Drug resistance updates Issue: Volume 21/22(2015) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future. Issue 4 (9th March 2021) Authors: Rayner, Craig R.; Smith, Patrick F.; Andes, David; Andrews, Kayla; Derendorf, Hartmut; Friberg, Lena E.; Hanna, Debra; Lepak, Alex; Mills, Edward; Polasek, Thomas M.; Roberts, Jason A.; Schuck, Virna; Shelton, Mark J.; Wesche, David; Rowland‐Yeo, Karen Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 4(2021) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance. Issue 1 (January 2021) Authors: Vanamala, Kushal; Tatiparti, Katyayani; Bhise, Ketki; Sau, Samaresh; Scheetz, Marc H.; Rybak, Michael J.; Andes, David; Iyer, Arun K. Journal: Drug discovery today Issue: Volume 26:Issue 1(2021) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗